Conwood Medipharma Private Limited
About Conwood Medipharma Private Limited
Data last updated:
Conwood Medipharma Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Indo-Gulf Diagnostics And Research Centre Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC167585.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Suman Kumar and Jasmin.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 1506 Hemkunt Chamber 89 Nehru Place, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2022, the company reported a revenue of ₹49.43 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 5.7%) and EBITDA of ₹49.34 Lakh (EBITDA margin 99.8%).
As per MCA filings, the company has open charges of ₹35.66 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Conwood Medipharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1506 Hemkunt Chamber 89 Nehru Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Conwood Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Conwood Medipharma Private Limited
FY 2022 filings availableConwood Medipharma Private Limited reported revenue of ₹49.43 Lakh (up 8% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.8% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Conwood Medipharma Private Limited, buy the company report.
Board of directors of Conwood Medipharma Private Limited
Conwood Medipharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumar Also directs: Roselle Infrastructure Private Limited, VC Infracon Private Limited, Ar Compusoft Private Limited and 1 more | Director | 23 Aug 2019 | 7 Years 2 Months | Current |
| Jasmin Also directs: Roselle Infrastructure Private Limited, VC Infracon Private Limited, Ar Compusoft Private Limited and 1 more | Director | 23 Aug 2019 | 7 Years 2 Months | Current |
| Sukhdev Kumar Also directs: Squarefoot Buildcon Private Limited, Roselle Infrastructure Private Limited, VC Infracon Private Limited and 5 more | Director | 31 Aug 2007 | 19 Years 1 Months | Current |
| Navdeep Kumar Also directs: Roselle Infrastructure Private Limited, Silversmith Infotech Private Limited, Saburi Infotech Private Limited and 2 more | Director | 12 Feb 2008 | 18 Years 8 Months | Current |
Peer comparison
Conwood Medipharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunrise Mediworld Private Limited | ₹49.72 Lakh (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| PRS Medicare Private Limited | ₹49.72 Lakh (FY 2024) | 3.0% | Vasai, Maharashtra, India | |||
| Xenomics Pharmaceuticals Private Limited | ₹49.71 Lakh (FY 2024) | 53.0% | Hyderabad, Telangana, India | |||
| Laurel Healthcare Private Limited | ₹49.69 Lakh (FY 2025) | -12.0% | Dehradun, Uttarakhand, India | |||
| Nagarika Generics India Private Limited | ₹49.51 Lakh (FY 2024) | 39.0% | Bangalore, Karnataka, India | |||
| Conwood Medipharma Private Limitedthis company | ₹49.43 Lakh (FY 2022) | ₹2.83 Lakh | 5.7% | 8.0% | New Delhi, Delhi, India | |
| Fivotech Lifesciences Private Limited | ₹49.37 Lakh (FY 2025) | -25.0% | Kamothe, Maharashtra, India | |||
| Neighbour Care Pharmaceuticals Private Limited | ₹49.34 Lakh (FY 2021) | -24.0% | Delhi, India | |||
| Pase Pharma Private Limited | ₹49.31 Lakh (FY 2025) | -9.0% | Delhi, India | |||
| Optha Vision Private Limited | ₹49.3 Lakh (FY 2025) | -19.0% | R Ngr, Uttar Pradesh, India | |||
| Raka Healthcare Private Limited | ₹49.29 Lakh (FY 2024) | 21.0% | Kukatpally Hyderabad, Telangana, India |
To see the full peer comparison of Conwood Medipharma Private Limited, buy the company report.
Auditor
Conwood Medipharma Private Limited is audited by P JAIN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P JAIN & CO | FY 2019 | 000711C |
Shareholding
The shareholding of Conwood Medipharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Conwood Medipharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2024 | 100964080 | Others | ₹59.6 Lakh | Open | |
| 11 Mar 2024 | 100891161 | Others | ₹4.41 Cr | Open | |
| 09 Jun 2023 | 100736524 | Others | ₹3.65 Cr | Open | |
| 20 Aug 2022 | 100608377 | Others | ₹9 Cr | Open | |
| 19 Aug 2022 | 100608425 | Others | ₹9 Cr | Open |
Total charge records: 6 View all charges
Legal cases
Conwood Medipharma Private Limited has 4 court cases on record: 3 filed by Conwood Medipharma, 1 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Greater Noida Industrial Development Authority and Another | Pending |
| High Court, UTTARPRADESH | Writ petition | Filed by the company against State of U.P. and 2 Others and 2 others | Disposed |
| High Court of Delhi | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-1 | Disposed |
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Greater Noida Industrial Devel. Authority and Another | Disposed |
To see the full case history of Conwood Medipharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Conwood Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Conwood Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Conwood Medipharma Private Limited has 7 board changes on record since 2007: 4 appointments and 3 cessations. The latest: Jasmin ceased to be Additional Director on 30 Sep 2019.
4 earlier events are in the company report.
Frequently asked questions
Conwood Medipharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 August 2007 (19+ years old) and is registered under CIN U24233DL2007PTC167585.
Conwood Medipharma has 4 current directors:
- Suman Kumar - Director
- Jasmin - Director
- Sukhdev Kumar - Director
- Navdeep Kumar - Director
The latest financial statements of Conwood Medipharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Conwood Medipharma is U24233DL2007PTC167585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Conwood Medipharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending.
Conwood Medipharma was incorporated on 31 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Conwood Medipharma by revenue are Sunrise Mediworld Private Limited, PRS Medicare Private Limited, Xenomics Pharmaceuticals Private Limited, Laurel Healthcare Private Limited, Nagarika Generics India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Jasmin ceased to be Additional Director on 30 Sep 2019. Suman Kumar ceased to be Additional Director on 30 Sep 2019. Jasmin was appointed as Director on 23 Aug 2019. Conwood Medipharma has 7 board changes on record in total.
The registered office of Conwood Medipharma is at 1506 Hemkunt Chamber 89 Nehru Place, New Delhi, Delhi, India – 110019.
Conwood Medipharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Conwood Medipharma has open charges of ₹35.66 Cr and no satisfied charges on record as per latest MCA filings.